Brief: Sun Life Financial Q2 Adjusted EPS CAD 1.79 Vs. IBES Estimate CAD 1.78

Sun Life Financial

07/08/2025 22:01

Overview

Sun Life Q2 underlying net income rises 2%, beating analyst expectations

Adjusted EPS for Q2 beats consensus, indicating strong operational performance

Company repurchased CAD 400 mln of shares, maintaining strong capital position

Outlook

Sun Life maintains strong capital position with LICAT ratio of 151%

Company emphasizes resilience in business mix amid external uncertainties

Sun Life continues strategic investments in digital initiatives

Result Drivers

ASIA GROWTH - Record underlying net income in Asia driven by strong protection business growth and increased bancassurance sales

HEALTH & PROTECTION - Improved U.S. Dental results and favorable mortality experience in Canada boosted Group - Health & Protection income

INDIVIDUAL PROTECTION CHALLENGES - Higher expenses and unfavorable mortality experience in Asia and North America impacted Individual - Protection income

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Adjusted EPS
Beat
C$1.79
C$1.78 (11 Analysts)
Q2 EPS
C$1.26
Q2 Adjusted Net Income
Beat
C$1.02 bln
C$1.01 bln (8 Analysts)
Q2 Net Income
C$716 mln
Q2 Adjusted ROE
17.6%
Q2 ROE
12.4%


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 4 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the life & health insurance peer group is "buy"

Wall Street's median 12-month price target for Sun Life Financial Inc is C$90.00, about 5.7% above its August 6 closing price of C$84.91

The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release: ID:nCNWpG71La

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)